Alpha Teknova (TKNO) Total Liabilities (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Total Liabilities came in at $33.7 million in Q1 2026, down 4.68% year-on-year from $35.4 million in Q1 2025, and down 3.09% on a QoQ basis from $34.8 million in Q4 2025.
Alpha Teknova (TKNO) Total Liabilities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Total Liabilities data on file, last reported at $33.7 million in Q1 2026.
- On a quarterly basis, Total Liabilities fell 4.68% year-over-year to $33.7 million in Q1 2026; TTM through Mar 2026 was $33.7 million, a 4.68% decrease from a year earlier, with the FY2025 full-year figure at $34.8 million, down 4.31% from the prior year.
- Total Liabilities for Q1 2026 stood at $33.7 million, down from $34.8 million in the prior quarter.
- Over the last five years, Total Liabilities for TKNO reached as high as $52.4 million in Q4 2022 and fell as low as $33.7 million in Q1 2026.
- Historically, Total Liabilities has averaged $40.5 million across 5 years, with a median of $37.4 million in 2024.
- Across the five-year window, Total Liabilities jumped 124.71% in 2022 and retreated 26.4% in 2023, its largest moves.
- Year by year, Total Liabilities stood at $52.4 million in 2022, then decreased by 26.4% to $38.6 million in 2023, then retreated by 5.64% to $36.4 million in 2024, then dropped by 4.31% to $34.8 million in 2025, then retreated by 3.09% to $33.7 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $33.7 million in Q1 2026, $34.8 million in Q4 2025, and $35.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 33.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.73 Mn |
| Dec 31, 2025 | 34.81 Mn |
| Sep 30, 2025 | 34.98 Mn |
| Jun 30, 2025 | 34.43 Mn |
| Mar 31, 2025 | 35.39 Mn |
| Dec 31, 2024 | 36.38 Mn |
| Sep 30, 2024 | 36.83 Mn |
| Jun 30, 2024 | 36.43 Mn |
| Mar 31, 2024 | 37.44 Mn |
| Dec 31, 2023 | 38.55 Mn |
| Sep 30, 2023 | 38.73 Mn |
| Jun 30, 2023 | 46.34 Mn |
| Mar 31, 2023 | 48.93 Mn |
| Dec 31, 2022 | 52.38 Mn |
| Sep 30, 2022 | 48.28 Mn |
| Jun 30, 2022 | 48.73 Mn |
| Mar 31, 2022 | 45.54 Mn |
| Dec 31, 2021 | 23.31 Mn |
| Sep 30, 2021 | 22.94 Mn |
| Jun 30, 2021 | 23.53 Mn |